Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NOTE | FISCALNOTE HOLDINGS INC | $97.66M | $0.61 | $2.42 | 299.50% | Strong Buy | 3 | -19.99% | N/A | -43.72% | -13.11% | |||
| CRUS | CIRRUS LOGIC INC | $4.97B | $93.55 | $114.25 | 22.13% | Strong Buy | 4 | 3.56% | 3.30% | 16.58% | 13.77% | |||
| SW | SMURFIT WESTROCK PLC | $22.11B | $42.35 | $59.14 | 39.65% | Strong Buy | 7 | N/A | N/A | N/A | N/A | |||
| NUVL | NUVALENT INC | $5.43B | $75.87 | $114.67 | 51.14% | Strong Buy | 3 | N/A | N/A | 7.23% | 6.77% | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $40.99M | $0.88 | $8.25 | 840.71% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| GPCR | STRUCTURE THERAPEUTICS INC | $1.48B | $25.91 | $72.33 | 179.17% | Strong Buy | 3 | N/A | N/A | -33.48% | -32.06% | |||
| PR | PERMIAN RESOURCES CORP | $9.80B | $12.20 | $18.63 | 52.66% | Strong Buy | 8 | 4.23% | 0.05% | 13.19% | 7.13% | |||
| XENE | XENON PHARMACEUTICALS INC | $2.94B | $38.37 | $58.00 | 51.16% | Strong Buy | 4 | N/A | N/A | -26.33% | -24.90% | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $776.26M | $7.28 | $43.00 | 490.66% | Strong Buy | 9 | N/A | N/A | -24.63% | -21.62% | |||
| BMEA | BIOMEA FUSION INC | $82.66M | $2.20 | $19.50 | 786.36% | Strong Buy | 4 | N/A | N/A | -205.08% | -132.31% | |||
| TRMB | TRIMBLE INC | $14.78B | $61.95 | $88.20 | 42.37% | Strong Buy | 5 | -7.20% | -61.55% | 11.18% | 6.77% | |||
| RNAC | CARTESIAN THERAPEUTICS INC | $308.29M | $11.90 | $41.00 | 244.54% | Strong Buy | 3 | -30.46% | N/A | N/A | -39.01% | |||
| ASH | ASHLAND INC | $2.52B | $53.48 | $76.50 | 43.04% | Strong Buy | 4 | 0.06% | N/A | N/A | N/A | |||
| BEAM | BEAM THERAPEUTICS INC | $1.65B | $19.71 | $48.43 | 145.71% | Strong Buy | 7 | 1.61% | N/A | -33.88% | -22.52% | |||
| PYXS | PYXIS ONCOLOGY INC | $64.05M | $1.04 | $8.67 | 733.37% | Strong Buy | 3 | -13.82% | N/A | -43.10% | -33.11% | |||
| GTN | GRAY MEDIA INC | $352.35M | $3.47 | $6.33 | 82.51% | Strong Buy | 3 | -3.29% | -41.76% | 2.13% | 0.46% | |||
| TECX | TECTONIC THERAPEUTIC INC | $377.45M | $20.23 | $71.50 | 253.52% | Strong Buy | 4 | N/A | N/A | -83.92% | -77.26% | |||
| CIVI | CIVITAS RESOURCES INC | $2.68B | $28.84 | $61.33 | 112.67% | Strong Buy | 9 | -2.73% | -8.86% | 17.37% | 7.71% | |||
| CTNM | CONTINEUM THERAPEUTICS INC | $114.09M | $4.41 | $23.75 | 438.55% | Strong Buy | 4 | N/A | N/A | -37.49% | -34.88% | |||
| KAPA | KAIROS PHARMA LTD | $13.54M | $0.81 | $8.33 | 927.50% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| SKYW | SKYWEST INC | $3.58B | $88.52 | $120.67 | 36.32% | Strong Buy | 3 | 5.23% | 3.68% | 16.68% | 5.80% | |||
| COYA | COYA THERAPEUTICS INC | $102.02M | $6.10 | $16.67 | 173.23% | Strong Buy | 3 | N/A | N/A | -57.26% | -51.10% | |||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $27.23M | $0.51 | $4.14 | 711.76% | Strong Buy | 5 | N/A | N/A | -34.53% | -26.55% | |||
| ACHR | ARCHER AVIATION INC | $4.88B | $8.99 | $12.57 | 39.83% | Strong Buy | 7 | N/A | N/A | -30.99% | -23.30% | |||
| VKTX | VIKING THERAPEUTICS INC | $3.14B | $27.94 | $79.00 | 182.75% | Strong Buy | 10 | N/A | N/A | -33.10% | -32.33% | |||
| AXTI | AXT INC | $61.56M | $1.35 | $5.33 | 295.04% | Strong Buy | 3 | 6.02% | N/A | 2.13% | 1.21% | |||
| MAZE | MAZE THERAPEUTICS INC | $384.97M | $8.79 | $25.67 | 192.00% | Strong Buy | 3 | -57.90% | N/A | N/A | -49.52% | |||
| SEPN | SEPTERNA INC | $307.99M | $6.93 | $33.00 | 376.19% | Strong Buy | 3 | N/A | N/A | -41.05% | -37.77% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.